Lilly buys AtaiBeckley·$3.8bnOtsuka buys Transcend·$1.2bnAbbVie buys Gilgamesh·$1.2bnatai buys Beckley Psytech·terms undisclosedAbbVie takes an option on Gilgamesh·$2bnLilly buys AtaiBeckley·$3.8bnOtsuka buys Transcend·$1.2bnAbbVie buys Gilgamesh·$1.2bnatai buys Beckley Psytech·terms undisclosedAbbVie takes an option on Gilgamesh·$2bnLilly buys AtaiBeckley·$3.8bnOtsuka buys Transcend·$1.2bnAbbVie buys Gilgamesh·$1.2bnatai buys Beckley Psytech·terms undisclosedAbbVie takes an option on Gilgamesh·$2bn
Next issueIssue 16 · Tue 29 Sep 

Companies

Slagelse Hospital

HQ
DK
Status
active
Listing
Private
Current stage
academic/clinical sponsor

euclinicaltrials.euregistryverified 2026-09-08

Notes on the record

Public hospital in Region Zealand, Denmark; not a company. Sponsor of record on CTIS for A010, sponsor type Hospital/Clinic/Other health care facility, non-commercial. No ClinicalTrials.gov record found for the trial on 2026-09-08 (sponsor, condition, intervention and EU CT number searches, all HTTP 200).

Assets

Registered trials

Deals

This company is not a party to any row in data/deals.csv.

In the briefing

1 issue tagged SLAGELSE.